Investigations of beta-lactams as novel bioactive compounds
Citation:
Shu Wang, 'Investigations of beta-lactams as novel bioactive compounds', [thesis], Trinity College (Dublin, Ireland). School of Pharmacy & Pharmaceutical Sciences, 2013, pp 502Download Item:
Abstract:
A natural stilbene product combretastatin A-4 (CA-4) is a known anti-cancer compound, which exerts its mechanism of action at the colchicine binding site on tubulin, a protein that is essential for the replication of cells. The synthesis and study of structure-activity relationships of a series of CA-4 analogues are described in which the four-member β-lactam heterocycle (azetidin-2-one) ring scaffold replaces the cis double bond in combretastatin A-4. A library of β-lactam compounds (CA-4 analogues) which are mimics of the substituted aryl ‘A’ ring and ‘B’ ring of CA-4 was synthesised using both Staudinger and Reformatsky reactions. Additional β-lactam compounds were prepared with diverse C-3 substitution at the β-lactam ring by Heck reaction, Diels-Alder reaction, aldol type reaction, alkylation and epoxidation reactions. A series of phosphate ester prodrugs and amino acid prodrugs were synthesised by suitable coupling reactions to improve the stability and solubility of the most active compounds.
Author: Wang, Shu
Advisor:
Meegan, Mary JanePublisher:
Trinity College (Dublin, Ireland). School of Pharmacy & Pharmaceutical SciencesNote:
TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ieType of material:
thesisCollections
Availability:
Full text availableMetadata
Show full item recordThe following license files are associated with this item: